Out now in #JCF! Remote follow-up visits can reduce costs and enhance pragmatic HF trials. In this analysis of CONNECT-HF, Satoshi Shoji, MD, PhD et al. evaluated the completeness and validity of the remote follow-ups. #ACC 🔗 Learn more: https://bit.ly/49uzN3e
Journal of Cardiac Failure’s Post
More Relevant Posts
-
Excited for the #ACC24 Late Breaking Clinical Trials!! A few that address #innovation #digitalhealth #accesstocare #collaborativeintelligence: **Remote Acute Assessment of Patients With High #Cardiovascular Risk Post-acute Coronary Syndrome (TELE-ACS) **Effect of #Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients With Elevated Risk For Major Adverse Cardiovascular Events. The Be Active Randomized Clinical Trial **The #Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) Study: A Randomized Evaluation of a Team-based Remote Education and Medication Management Program to Reduce CV and Kidney Risk **Health 360x Registry: Scalable #Workforce For Equitable Access to Point of Care #decentralizedclinicaltrials **Hózhó (#HeartFailure Optimization at Home to Improve Outcomes): A Pragmatic Clinical Trial of Telephone-based Guideline-directed Medical Therapy Optimization in Navajo Nation **Advancing Acute MI Care in Densely Populated LMICs: Innovative Standalone #ChestPain Units For Expedited Triage and Timely Management – A Role Model For #Global Healthcare Systems American College of Cardiology Harlan Krumholz Christopher Cannon, MD Sachin H. Jain, MD, MBA Jennifer Goldsack Kendal K. Whitlock, MPH Helen Burstin Daniel Kraft, MD Jennifer N. Avari Silva David Cho Katie Berlacher James Januzzi Cathy Gates Cathie Biga Nicole Napoli Joyce Donnellan Shalen F.
🚨 #ACC24 Breaking News 🚨 The ACC.24 Late-Breaking Clinical Trials are out! Some of the trials being presented are: ◼️ RELIEVE-HF ◼️ EMPACT-MI ◼️ AEGIS-II ◼️ VICTORION-INITIATE ◼️ Step-HFpEF Dm ◼️ TELE-ACS ◼️ BRIDGE-TIMI 73a Learn more & see the full list of trials: https://bit.ly/47UvZYt
To view or add a comment, sign in
-
Miss Solomon Banjo’s presentation at #DIA2024 on the imperatives successful IDN partnerships will require in the future? Or not at DIA and want to learn? 💡Access our key insights here: https://lnkd.in/efhvVhup
To view or add a comment, sign in
-
Does moving from NBI to SNBI standards seem like a challenge? Transitioning from NBI to SNBI standards is more than a simple update—it's a significant leap. For many agencies, this transition reveals several new challenges that must be navigated carefully. Recognizing these difficulties, the FHWA developed a Transition Tool, but it has limitations. These challenges are just the tip of the iceberg. To tackle them head-on, our SNBIX tool offers a seamless path to SNBI compliance, simplifying the process for agencies. Curious to learn more? Check out our latest blog showcasing how SNBIX enables a smooth and seamless transition from NBI to SNBI standards. https://lnkd.in/gqFXzZgC Have more questions? We would love to connect and discuss in detail. Schedule a demo. https://lnkd.in/dwmvC7yr #AssetIntel #NBItoSNBI #SNBIX #bridgeinspections #engineering #DataTransition #Innovations #techforgov #departmentoftransportation
To view or add a comment, sign in
-
Stay one step ahead of the criminals: Gain an invaluable edge with Andrew Marr's insights into evolving ATM Attack Threats and Solutions. Don't miss this powerhouse speaker and a conference packed with knowledge! #CompetitiveAdvantage #ATMSecurityStrategies #ATMIA2024 #ATMIA #ATMs #ATMIndustry #atmsecurity
ATMIA is proud to announce that Andrew Marr of #3SISecuritySystems will be presenting at the #ATMIA2024 conference!
To view or add a comment, sign in
-
Stay one step ahead of the criminals: Gain an invaluable edge with Andrew Marr's insights into evolving ATM Attack Threats and Solutions. Don't miss this powerhouse speaker and a conference packed with knowledge! #CompetitiveAdvantage #ATMSecurityStrategies #ATMIA2024 #ATMIA #ATMs #ATMIndustry #atmsecurity
ATMIA is proud to announce that Andrew Marr of #3SISecuritySystems will be presenting at the #ATMIA2024 conference!
New Speaker Announcement!
atmia.com
To view or add a comment, sign in
-
Starting Session 5 – Regulator-Industry Dialogue on Digital Connectivity at #SATRC25, focusing on efficient spectrum use. Moderated by Mr. Bhupendra Bhandari, Chairman of the NTA, with discussions on ensuring spectrum access, creating transparent policies, & harmonizing usage!
To view or add a comment, sign in
-
🔆 🔸 DRFP ALERT 🔸 🔆 WE VALUE YOUR FEEDBACK AND WANT TO HEAR FROM YOU! See the latest RFI, which has been updated to a DRFP here: https://lnkd.in/gqjSAdH5 #DRFP #ArmyDigitalOdyssey #ArmyModernization #InformationSharing
To view or add a comment, sign in
-
I am so glad to share my research: Hierarchical Framework for Processing Wi-Fi Log Data and Characterizing Community Human Mobility at ASCE ICTD conference in Atlanta, Georgia. Please feel free to join me at the poster session from 1.30pm to 2.45pm, June 17. #ICTD24 #APMATS24
To view or add a comment, sign in
-
IN CASE YOU MISSED IT! Check out the latest online issue of the July 2024 TXIA Connect. Use the following link to access the electronic version of #TXIAConnect today: https://lnkd.in/gdDtTMU
To view or add a comment, sign in
-
Exciting news! The groundbreaking DanGer Shock RCT results, now published in NEJM and presented at #ACC24, signify a significant advancement in treating Acute Myocardial Infarction Complicated by Cardiogenic Shock (AMICS). This independent study is historic, marking the first time in AMICS trial history that a Randomized Controlled Trial (RCT) achieved its primary survival endpoint. Additionally, it's the first RCT within the Mechanical Circulatory Support (MCS) device trial history to show a survival benefit in AMICS. Learn more about this landmark achievement and its implications for cardiac care. #Cardiology #MedicalResearch #IntelMed Abiomed https://lnkd.in/dUxM-KHc
The results of the DanGer Shock RCT were published in NEJM today and presented as an #ACC24 Late-Breaker. This independent investigator-initiated study represents a landmark as: ➡ The first RCT in AMICS trial history to achieve its primary survival endpoint. ➡The first RCT in the MCS device trial history to demonstrate a survival benefit in AMICS. Learn more: https://lnkd.in/eVjHNABc
Dr. Jacob Møller on the DanGer Shock RCT
To view or add a comment, sign in
391 followers